Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)-Reference-Cited by-同舟云学术

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)

Published:2020-05-28 Issue:suppl 1 Volume:14 Page:979-988
ISSN:2581-690X
Container-title:Journal of Pure and Applied Microbiology
language:en
Short-container-title:J. Pure Appl. Microbiol.

Author:

Bhadra Abhi^ORCID,Singh Shweta^ORCID,Chandrakar Shaswat^ORCID,Kumar Vanshika^ORCID,Sankhla Sakshi^ORCID,Raj T. Sayuj^ORCID,Selvarajan E.^ORCID

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has reached global epidemic status claiming more than 319K lives and affecting more than 4.81M people and counting worldwide. Considering the severity of the situation and low recovery rate many research institutions and pharmaceutical industries are rushing to learn more about this new virus and the morbid physiology of this disease with effective diagnostic methods, therapeutic agents and vaccines. Various approaches are highlighted for comparing the possible treatment methods available for COVID-19 some of which are BCG vaccination on COVID-19 and Non-pharmaceutical interventions, drug based clinical trials of Hydroxychloroquine-Azithromycin, chloroquine, lopinavir/ritonavir, ChAdOx1 nCoV-19, Remdesivir, Stem Cell therapy and mesenchymal stromal cell therapy, etc.

Publisher

Journal of Pure and Applied Microbiology

Subject

Applied Microbiology and Biotechnology,Microbiology,Biotechnology

Reference32 articles.

1. 1. Culp W C. Coronavirus Disease 2019. A A Pract. 2020;14(6):e01218-e01218. https://doi.org/10.1213/XAA.0000000000001218

2. 2. Franks TJ & Galvin JR. Coronavirus. in Viruses and the Lung: Infections and Non-Infectious Viral-Linked Lung Disorders. 2014;109-116. https://doi.org/10.1007/978-3-642-40605-8_13

3. 3. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology. 2019;17(3):181-192. https://doi.org/10.1038/s41579-018-0118-9

4. 4. Zhu N et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727-733. https://doi.org/10.1056/NEJMoa2001017

5. 5. Liu C et al. Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases. ACS Cent. Sci. 2020;6(3):315-331.6. https://doi.org/10.1021/acscentsci.0c00272

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysing the impact of the two most common SARS-CoV-2 nucleocapsid protein variants on interactions with membrane protein in silico;Journal of Genetic Engineering and Biotechnology;2021-09-20